| Drug Name |
Encainide hydrochloride |
| Drug ID |
BADD_D00769 |
| Description |
All drug products containing encainide hydrochloride. Encainide hydrochloride, formerly marketed as Enkaid capsules, was associated with increased death rates in patients who had asymptomatic heart rhythm abnormalities after a recent heart attack. The manufacturer of Enkaid capsules voluntarily withdrew the product from the US market on December 16, 1991. |
| Indications and Usage |
Encainide is a class Ic antiarrhythmic agent which was used for management of irregular heartbeats, such as atrial fibrillation, atrial flutter, ventricular tachycardia, and ventricular fibrillation. |
| Marketing Status |
approved; investigational; withdrawn |
| ATC Code |
C01BC08 |
| DrugBank ID |
DB01228
|
| KEGG ID |
D03991
|
| MeSH ID |
D016700
|
| PubChem ID |
48040
|
| TTD Drug ID |
D06PAZ
|
| NDC Product Code |
Not Available |
| UNII |
4CH7J36N9S
|
| Synonyms |
Encainide | Encainide, (+)-Isomer | Enkaid | MJ-9067 | MJ 9067 | MJ9067 | Encainide Hydrochloride | Encainide Hydrochloride, (+-)-Isomer | Encainide, (-)-Isomer |
